PriceTargets.com logo

Amdocs - DOX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $102.50
  • Forecasted Upside: 7.74%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$95.14 As of 06/2/2023 12:02 PM ET
▲ +0.61 (0.65%)

This chart shows the closing price for DOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Amdocs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOX

Analyst Price Target is $102.50
▲ +7.74% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Amdocs in the last 3 months. The average price target is $102.50, with a high forecast of $115.00 and a low forecast of $96.00. The average price target represents a 7.74% upside from the last price of $95.14.

This chart shows the closing price for DOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Amdocs. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/2/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2023BarclaysUpgradeEqual Weight ➝ Overweight$100.00 ➝ $115.00Low
5/11/2023888Reiterated RatingReiteratesLow
2/2/2023Robert W. BairdBoost TargetNeutral$85.00 ➝ $100.00Low
2/1/2023OppenheimerBoost TargetOutperform$94.00 ➝ $99.00Low
11/15/2022BarclaysBoost Target$100.00Low
11/15/2022Robert W. BairdLower Target$85.00Low
11/10/2022OppenheimerReiterated RatingOutperform ➝ Outperform$84.00Low
11/9/2022OppenheimerLower Target$99.00 ➝ $94.00Low
11/9/2022CitigroupLower TargetBuy$99.00 ➝ $96.00Low
8/4/2022CitigroupBoost TargetBuy$90.00 ➝ $99.00Low
8/4/2022BarclaysBoost TargetEqual Weight$89.00 ➝ $95.00Low
5/13/2022OppenheimerReiterated RatingOutperform ➝ Top PickLow
5/12/2022CitigroupLower Target$93.00 ➝ $90.00High
12/14/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$91.00 ➝ $86.00Low
8/5/2021OppenheimerBoost TargetOutperform$84.00 ➝ $99.00Medium
4/9/2021OppenheimerReiterated RatingBuyLow
2/11/2021OppenheimerReiterated RatingOutperform$84.00Low
2/3/2021CitigroupBoost Target$82.00 ➝ $87.00Low
11/11/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$75.00High
8/12/2020OppenheimerReiterated RatingBuy$75.00Medium
8/6/2020OppenheimerReiterated RatingBuy$75.00High
5/11/2020CitigroupLower TargetBuy$83.00 ➝ $76.00Low
2/5/2020OppenheimerBoost TargetOutperform$77.00 ➝ $85.00Medium
2/5/2020Robert W. BairdBoost TargetNeutral$69.00 ➝ $74.00High
1/15/2020CitigroupBoost TargetBuy$72.00 ➝ $83.00Low
11/15/2019Stifel NicolausBoost TargetPositive ➝ Buy$70.00 ➝ $75.00Low
11/13/2019JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$75.00 ➝ $72.00High
8/8/2019JPMorgan Chase & Co.Boost TargetNeutral$67.00 ➝ $75.00High
5/15/2019JPMorgan Chase & Co.Lower TargetNeutral$70.00 ➝ $67.00High
1/10/2019JPMorgan Chase & Co.Reiterated RatingHoldLow
12/11/2018JPMorgan Chase & Co.Set TargetHold$70.00Low
8/2/2018Robert W. BairdReiterated RatingHold$72.00Medium
8/2/2018CitigroupLower TargetBuy ➝ Buy$79.00 ➝ $77.00Low
8/1/2018BarclaysSet TargetHold$73.00High
(Data available from 6/2/2018 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 9 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2022
  • 11 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2022
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2023
  • 10 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2023
  • 16 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2023
  • 10 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2023
  • 10 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2023
  • 15 very positive mentions
  • 24 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2023

Current Sentiment

  • 15 very positive mentions
  • 24 positive mentions
  • 8 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Amdocs logo
Amdocs Ltd. is a holding company, which engages in the provision of software products and services for the communications, entertainment, and media industry service providers. The company was founded in 1988 and is headquartered in Saint Louis, MO.
Read More

Today's Range

Now: $95.14
Low: $94.44
High: $95.25

50 Day Range

MA: $93.59
Low: $88.83
High: $96.75

52 Week Range

Now: $95.14
Low: $76.79
High: $97.08

Volume

78,639 shs

Average Volume

657,299 shs

Market Capitalization

$11.49 billion

P/E Ratio

21.67

Dividend Yield

1.85%

Beta

0.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Amdocs?

The following sell-side analysts have issued stock ratings on Amdocs in the last twelve months: 888 Holdings plc, Barclays PLC, Citigroup Inc., Oppenheimer Holdings Inc., Robert W. Baird, and StockNews.com.
View the latest analyst ratings for DOX.

What is the current price target for Amdocs?

4 Wall Street analysts have set twelve-month price targets for Amdocs in the last year. Their average twelve-month price target is $102.50, suggesting a possible upside of 7.7%. Barclays PLC has the highest price target set, predicting DOX will reach $115.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $96.00 for Amdocs in the next year.
View the latest price targets for DOX.

What is the current consensus analyst rating for Amdocs?

Amdocs currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DOX will outperform the market and that investors should add to their positions of Amdocs.
View the latest ratings for DOX.

What other companies compete with Amdocs?

Other companies that are similar to Amdocs include EPAM Systems, Cognizant Technology Solutions, Aspen Technology, Zscaler and VeriSign. Learn More about companies similar to Amdocs.

How do I contact Amdocs' investor relations team?

Amdocs' physical mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company's listed phone number is (314) 212-7000 and its investor relations email address is [email protected]. The official website for Amdocs is www.amdocs.com. Learn More about contacing Amdocs investor relations.